Pam Rajendran Taub MD
Non-Invasive Cardiology, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation
Professor of Medicine, UCSD School of Medicine Director of Cardiac Wellness and Rehabilitation
Join to View Full Profile
9300 Campus Point DrLa Jolla, CA 92037
Phone+1 858-248-1308
Dr. Taub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 2007 - 2010
University of WashingtonResidency, Internal Medicine, 2005 - 2007
Boston University School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2004 - 2026
WA State Medical License 2005 - 2008
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Effects of Dark Chocolate on Exercise Capacity, and Mitochondrial Structure and Function Start of enrollment: 2012 Jul 01
- Effects of Epicatechin on Functional Capacity, Skeletal Muscle Structure and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction (HFPEF) Start of enrollment: 2014 Jan 01
- Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity Start of enrollment: 2015 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Generalizability of VICTORION-1 PREVENT enrollment criteria to the United States population.Rahul Aggarwal, Deepak L Bhatt, Marc P Bonaca, Catrin Deck, Anastasia Lesogor
American Journal of Preventive Cardiology. 2025-06-01 - The role of finerenone in the concomitant management of chronic kidney disease-type 2 diabetes and the implication for heart failure prevention and treatment.Pam R Taub, Stephen J Greene, Marat Fudim
Heart Failure Reviews. 2025-05-31 - Enhancement of Statin Effects on Lipid Lowering and Reduction of Cardiovascular Risk Score by (-)-Epicatechin in Proof-of-Concept Pilot Study.Cameron K Ormiston, Aryana Pazargadi, Ashley Rosander, Guillermo Ceballos, Francisco Villarreal
Clinical and Translational Science. 2025-05-01
Journal Articles
- Correction to: Mitochondrial H+-ATP Synthase in Human Skeletal Muscle: Contribution to Dyslipidaemia and Insulin ResistancePam Taub, Robert R Henry, Diabetologia
Lectures
- Pearls In Lifestyle Related Prevention Every Cardiology Practitioner Needs to Know2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- The Mind-Body-Heart Connection: What's the evidence?2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Barriers to Cardiac Rehabilitation: How Do We Overcome Issues With Adherence and Cost?2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019
Press Mentions
Inclisiran Effective as Monotherapy for Lower-Risk Primary PreventionMay 7th, 2025- Metabolic Syndrome Is a Big Risk Factor for Early Dementia, and What You Do Makes a Difference, Study SuggestsApril 23rd, 2025
- FDA Clears First Blood Test of Its Kind for Lp(A)January 29th, 2025
- Join now to see all
Grant Support
- Impact of Time-Restricted Feeding (TRF) on Glucose Homeostasis and Mitochondrial Function in Patients with Metabolic SyndromeUNIVERSITY OF CALIFORNIA, SAN DIEGO2018–2030
Professional Memberships
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
